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We and other groups have studied the regulatory mechanism of
human FoF1-ATP synthase, especially, mechanism related to IF1
(inhibitor of F1) [1]. It is thought that IF1 in mammalian mitochondria
inhibits ATP hydrolysis when cells encounter conditions unfavorable
for synthesis such as ischemia. Factors other than IF1 may be also
involved in the regulation of human FoF1-ATP synthase activity as
demonstrated by the recent reports on the effect of PKC delta and
TMEM70. However, collective screening of the regulatory factors of
mitochondrial ATP synthesis has not been done mainly because there
is no high throughput assay for mammalian FoF1-ATP synthase activity.
Conventional protocol to measure FoF1 activity requires sub-cellular
fractionation from large amounts of culture cells. Furthermore, the
puriﬁed mitochondrial fractions should be used in short time due to
rapid decay of the ATP synthesis activity. We invented new assay
method for the mitochondrial ATP synthesis activity of human culture
cells. We utilize streptolysin O (SLO) to make pores in plasma mem-
brane of host cells without damaging organelle membranes. Cytosolic
components are washed out and mitochondrial ATP synthesis activity
is measured (Biochem. Biophys. Res. Commun., 2010, 401 (4) 538–
543). The new method, MASC (Mitochondrial Activity of SLO-
permeabilized Cells) assay, enables us to directly measure ATP
synthesis activity of FoF1 of culture cells on 96-well plate, suitable
for high throughput screening for factors that affect ATP synthesis.
First, factors assumed to be interacting with FoF1-ATP synthase were
knocked down and screened. By this screening, DAPIT (J. Biol. Chem.,
2011, 286 (23) 20292– 20296) was found to be essential for ATP
synthesis of FoF1. Next, unknowngenes codingmitochondrially localized
proteins were knocked down and screened. By this screening, a critical
gene for FoF1 activity was found. To summarize, we established a new
screening method for human FoF1-ATP synthase activity and found
new factors that are essential for ATP synthesis activity.
[1] J. Biol. Chem., 2012, 287 (22) 18781-7
doi:10.1016/j.bbabio.2012.06.046
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The mitochondrial FOF1ATP synthase is a large multisubunit
complex of 600 kDa anchored to the inner mitochondrial membrane,
where it catalyzes ATP synthesis or hydrolysis at high and low proton
electrochemical gradient, respectively. We have previously demon-
strated that Cyclophilin D (CyPD, the only known mitochondrial
immunophilin) binds the lateral stalk and inhibits the ATP synthase.
The exact binding site in the lateral stalk and the mechanism(s)
through which CyPD modulates ATP-synthesis/hydrolysis have not
been deﬁned yet. Here we studied the association of CyPD to ATP
synthase in bovine, human and mouse heart mitochondria in order to
deﬁne the site and mechanism of interaction. We found that OSCP
subunit is the binding site for CyPD; consistently (i) decreasing the
amount of OSCP subunit by RNA interference also reduced CyPD
association to the ATP synthase; (ii) Benzodiazepine 423 (Bz423, an
OSCP subunit-targeted inhibitor of FOF1ATP synthase) inhibited ATP
hydrolysis both in wild-type and in CyPD-null mitochondria, yet
higher Bz423 concentrations were required to inhibit the ATP synthase
in wild-type mitochondria, where the drug displaced CyPD from the
enzyme complex. Since Bz423 binds OSCP helices 3 and 4, these data
suggest that CyPD binding speciﬁcally affects this site on the ATP
synthase. Consistentwith a site-speciﬁc effect of Bz423, no difference in
inhibitory titer between wild-type and CyPD-null mitochondria was
observed with oligomycin (which inhibits the ATP synthase at subunit
a) and resveratrol (which binds the α/β subunits). Like binding of
Bz423 to OSCP, the interaction between CyPD and the lateral stalk of the
ATP synthase was disrupted by increasing ionic strength, suggesting
that the interaction itself is electrostatic in nature.
doi:10.1016/j.bbabio.2012.06.047
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Movements of the ε-subunit of the H+-ATPsynthase from
Escherichia coli (EFOF1) are investigated by single molecule spectros-
copy. Two mutants of EFOF1 that differ in the binding site of the ﬂuo-
rescent dye on the ε-subunit (εA93C and εY114C) have been used.
Both mutants have the same binding site on the γ-subunit (γT106C).
The ε- and the γ-subunits of EFOF1 have been covalently labeled with
ﬂuorescent dyes. Depending on the investigated distances two ﬂuores-
cents pairs, ATTO 532/ATTO 610 or ATTO 532/ATTO 647N, have been
used. The labeled EFOF1 is integrated into liposomes. Single-pair ﬂuo
rescence resonance energy transfer is measured in freely diffusing
proteoliposomes with a confocal two channel microscope. It has been
shown with both mutants that addition of the nucleotide ADP changes
the conformation of the ε-subunit from the “up” conformation to the
“up extended” conformation. Addition of the nucleotides ATP or
AMPPNP changes the “up” conformation to the “down” conformation.
doi:10.1016/j.bbabio.2012.06.048
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Energy metabolism has emerged as a new target-pathway for de-
velopment of new anti-tubercular drugs [1], which are urgently needed
to combat concomitantly emerging drug-resistant bacterial strains. A
new ATP synthase inhibitor [2], the diarylquinoline TMC207, acts in a
highly selective manner with strong afﬁnity for ATP synthase from
Mycobacterium tuberculosis and only minimal effect on the human
homologue [3]. These features are prerequisite for clinical application
of ATP synthase inhibitors and make TMC207 a promising drug
candidate for shortening and simplifying tuberculosis chemotherapy.
We used biochemical assays and binding studies to characterize
the interaction between TMC207 and ATP synthase [3]. Using
inverted membrane vesicles from the non-pathogenic strain M. bovis
BCG [4] we show that TMC207 acts independent of the proton motive
force and does not compete with protons for a common binding site.
The drug is active on mycobacterial ATP synthesis at neutral and
acidic pH with no signiﬁcant change in afﬁnity between pH 5.25 and
pH 7.5 (IC50 = 5-10 nM), indicating that the protonated form of
TMC207 is the active drug entity. The interaction of TMC207 with ATP
synthase can be explained by a one-site binding mechanism, the
drug molecule thus binds to a deﬁned binding site on ATP synthase.
TMC207 afﬁnity for its target decreases with increasing ionic
strength, suggesting that electrostatic forces play a signiﬁcant role
in drug binding. These results will be discussed in view of existing
docking studies and may provide input for structure-based design of
ATP synthase inhibitors. Moreover, the high afﬁnity of TMC207
observed at low proton motive force and low pH values may in part
explain the exceptional ability of this compound to efﬁciently kill
mycobacteria in different microenvironments.
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Isolated ATP synthase deﬁciency of nuclear origin leads to a rather
frequent fatal neonatal encephalo-cardiomyopathy (OMIM604273).
The most common cause of the disease is c.317-2ANG mutation in
TMEM70 gene, coding for speciﬁc factor of mitochondrial ATP
synthase biogenesis with unknown function [1]. Characterization of
TMEM70 protein properties is thus necessary for elucidation of
its biological role and better understanding of the pathogenic
mechanism of the disease. In this study we analyzed in detail the
biosynthesis and presumed mitochondrial localization of the protein
using cells expressing GFP- or FLAG-tagged forms of TMEM70 protein
as the experimental model. We have found that TMEM70 gene
encoded precursor of 29 kDa is processed into 21 kDa mature protein.
The import study revealed that the TMEM70 protein is processed
after transport into mitochondrial matrix, but the level of transported
protein and its cellular content are very low. Immuno-cytochemical
analysis and fractionation of mitochondria conﬁrmed the localization
of the TMEM70 protein in the inner mitochondrial membrane [2].
Accessibility of the tagged forms of TMEM70 protein to trypsin
followed by electrophoretic or microscopic analysis demonstrated the
orientation of C- and N- protein termini into mitochondrial matrix.
2D BN/SDS electrophoretic analysis of digitonin-solubilized proteins
further showed, that TMEM70 protein is able either form an
oligomeric structures or associate with other, yet unknown proteins.
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Introduction and aim
In order to develop a ﬂow reaction chamber for the continuous cell
free protein synthesis, one key challenge is to provide energy in form
of Adenosine 5′-triphosphate (ATP) for the process. To feed the
system with ATP molecules from an external source is one strategy to
solve this problem. However in this case, the major drawback is that
the reaction products Adenosine 5′-diphosphate (ADP) and phos-
phate accumulate in the reaction solution and have to be removed
frequently. Another approach is the direct regeneration of ATP from
ADP and the phosphate molecule within the reaction compartment.
Therefore, our aim is to isolate the ATP-Synthases from Escherichia
coli and to immobilize these proteins onto custom made carrier
membranes. In the presented work, an ATP regeneration module is
designed employing computational modeling to transfer a batch
reaction into a continuous protein synthesis process.
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